Reaction

Catheter Site Nodule reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 156 reports · 4 co-occurring drugs

As of the last recalculation, Catheter Site Nodule appears in 156 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 156.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol14156.7156.8
Amantadine11102.0102.1
Carbidopa And Levodopa2375.775.7
Rasagiline Mesylate561.961.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.